CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
Sep. 28, 2013	Sep. 29, 2012
Operating Activities:
Net income	$ 236,763	$ 201,337
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and accretion	59,639	47,146
Stock-based compensation	11,062	12,858
Decrease in allowance for returns-net of inventory in transit	(3,586)	(2,929)
Loss on disposal of assets	660	1,473
Impairment losses	0	256
Equity in income of joint venture	0	(815)
Gain on equity method investment	(6,510)	0
Decrease in allowance for doubtful accounts	(6,200)	(3,047)
Excess tax benefits from stock-based compensation	(7,204)	(11,223)
Deferred income taxes and other	5,968	4,836
Contingent consideration revaluation	0	(3,585)
Changes in operating assets and liabilities:
Accounts receivable	22,919	41,043
Inventories	(144,726)	(78,487)
Prepaid expenses and other current assets	(9,512)	(1,866)
Accounts payable	14,368	(28,586)
Accrued expenses	(4,806)	(50,141)
Income taxes payable	11,118	40,231
Net cash provided by operating activities	179,953	168,501
Investing Activities:
Additions to property, plant and equipment	(66,334)	(59,710)
Increase in intangible and other assets	(8,959)	(4,980)
Proceeds from the sale of property, plant and equipment, and other	2,027	21
Net change in restricted cash	424	6,903
Business acquisitions-net of cash acquired	(14,896)	(229,151)
Net cash used in investing activities	(87,738)	(286,917)
Financing Activities:
Acquisition of common stock	(460,413)	(205,631)
Distribution of noncontrolling interest earnings	(4,679)	(4,406)
Excess tax benefits from stock-based compensation	7,204	11,223
Debt borrowings	960,116	399,198
Debt payments	(554,078)	(235,688)
Proceeds from exercise of stock options	6,203	5,279
Net cash used in financing activities	(45,647)	(30,025)
Effect of exchange rate changes on cash and cash equivalents	5,095	3,780
Net increase (decrease) in cash and cash equivalents	51,663	(144,661)
Cash and cash equivalents:
Beginning of period	177,236	287,498
End of period	$ 228,899	$ 142,837

This item represents the entity's proportionate share for the period of the noncash items making up net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.

No definition available.